source
- FDA acting commissioner says Makary’s journal policies are not official guidance; UK regulator reports rise in drug approvals and AI stepsThe acting commissioner of the U.S. Food and Drug Administration clarified that the policies published in medical journals by former commissioner Marty Makary do not constitute official FDA policy…
- Attovia Therapeutics and Braveheart Bio announce plans for biotech IPOs amid market upswingAttovia Therapeutics and Braveheart Bio disclosed on Tuesday that they intend to go public, joining a recent wave of large biotech offerings. Attovia, which was spun out of Alamar Biosciences in 2…